| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9356 | 
      | Human Intestinal Absorption | HIA+ | 0.9566 | 
      | Caco-2 Permeability | Caco2- | 0.8283 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7853 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9158 | 
                                                     | Non-inhibitor | 0.9205 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8344 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4011 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7789 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8909 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7568 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8933 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.7501 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9221 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.6564 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7892 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8102 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9046 | 
                                                                    | Non-inhibitor | 0.9034 | 
      | AMES Toxicity | Non AMES toxic | 0.8408 | 
      | Carcinogens | Non-carcinogens | 0.8281 | 
      | Fish Toxicity | High FHMT | 0.7427 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.5538 | 
      | Honey Bee Toxicity | Low HBT | 0.7989 | 
      | Biodegradation | Not ready biodegradable | 0.9902 | 
      | Acute Oral Toxicity | III | 0.7402 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5665 |